Terms: = Brain cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Prognosis
18 results:
1. Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast cancer brain Metastasis.
Lim M; Fletcher NL; Saunus JM; McCart Reed AE; Chittoory H; Simpson PT; Thurecht KJ; Lakhani SR
Mol Pharm; 2023 Dec; 20(12):6169-6183. PubMed ID: 37970806
[TBL] [Abstract] [Full Text] [Related]
2. Association of the m
Li Y; Cao J; Wang J; Wu W; Jiang L; Sun X
Cancer; 2024 Feb; 130(3):356-374. PubMed ID: 37861451
[TBL] [Abstract] [Full Text] [Related]
3. The expression and prognostic value of the epidermal growth factor receptor family in glioma.
Xu B; Huo Z; Huang H; Ji W; Bian Z; Jiao J; Sun J; Shao J
BMC Cancer; 2021 Apr; 21(1):451. PubMed ID: 33892666
[TBL] [Abstract] [Full Text] [Related]
4. A structural view of PA2G4 isoforms with opposing functions in cancer.
Stevenson BW; Gorman MA; Koach J; Cheung BB; Marshall GM; Parker MW; Holien JK
J Biol Chem; 2020 Nov; 295(47):16100-16112. PubMed ID: 32952126
[TBL] [Abstract] [Full Text] [Related]
5. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.
Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N
Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240
[TBL] [Abstract] [Full Text] [Related]
6. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
7. Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer.
Maisel SA; Broka D; Atwell B; Bunch T; Kupp R; Singh SK; Mehta S; Schroeder J
J Transl Med; 2019 Jun; 17(1):201. PubMed ID: 31215437
[TBL] [Abstract] [Full Text] [Related]
8. Innovative Therapeutic Strategies for Effective Treatment of brain Metastases.
Lim M; Puttick S; Houston ZH; Thurecht KJ; Kalita-de Croft P; Mahler S; Rose SE; Jeffree RL; Mazzieri R; Dolcetti R; Lakhani SR; Saunus JM
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875730
[TBL] [Abstract] [Full Text] [Related]
9. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka SM; Bebb DG; Cheung WY
Med Oncol; 2018 Aug; 35(9):117. PubMed ID: 30073425
[TBL] [Abstract] [Full Text] [Related]
10. Lapatinib.
Voigtlaender M; Schneider-Merck T; Trepel M
Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757
[TBL] [Abstract] [Full Text] [Related]
11. CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary.
Bachmann C; Grischke EM; Fehm T; Staebler A; Schittenhelm J; Wallwiener D
J Cancer Res Clin Oncol; 2013 Apr; 139(4):551-6. PubMed ID: 23224376
[TBL] [Abstract] [Full Text] [Related]
12. Negative regulation of p53 by the long isoform of erbb3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract] [Full Text] [Related]
13. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract] [Full Text] [Related]
14. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
Andersson U; Schwartzbaum J; Wiklund F; Sjöström S; Liu Y; Tsavachidis S; Ahlbom A; Auvinen A; Collatz-Laier H; Feychting M; Johansen C; Kiuru A; Lönn S; Schoemaker MJ; Swerdlow AJ; Henriksson R; Bondy M; Melin B
Acta Oncol; 2010 Aug; 49(6):767-75. PubMed ID: 20446891
[TBL] [Abstract] [Full Text] [Related]
15. Bevacizumab for recurrent ependymoma.
Green RM; Cloughesy TF; Stupp R; DeAngelis LM; Woyshner EA; Ney DE; Lassman AB
Neurology; 2009 Nov; 73(20):1677-80. PubMed ID: 19917990
[TBL] [Abstract] [Full Text] [Related]
16. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
[TBL] [Abstract] [Full Text] [Related]
17. Unique molecular characteristics of radiation-induced glioblastoma.
Donson AM; Erwin NS; Kleinschmidt-DeMasters BK; Madden JR; Addo-Yobo SO; Foreman NK
J Neuropathol Exp Neurol; 2007 Aug; 66(8):740-9. PubMed ID: 17882018
[TBL] [Abstract] [Full Text] [Related]
18. CI-1033, a pan-erbB tyrosine kinase inhibitor.
Slichenmyer WJ; Elliott WL; Fry DW
Semin Oncol; 2001 Oct; 28(5 Suppl 16):80-5. PubMed ID: 11706399
[TBL] [Abstract] [Full Text] [Related]
